PROVEXIS PLC Logo

PROVEXIS PLC

Develops and licenses functional ingredients for the food and supplement markets.

PXS | IL

Overview

Corporate Details

ISIN(s):
GB00B0923P27
LEI:
21380042E3Y3N9VZ6N48
Country:
United Kingdom
Address:
2 BLAGRAVE STREET, RG1 1AZ READING

Description

Provexis PLC is a life sciences company that develops, licenses, and commercializes functional ingredients for the global food, beverage, and dietary supplement markets. The company's principal technology is Fruitflow®, a patented, scientifically-proven bioactive ingredient derived from tomatoes. Fruitflow® is designed to support cardiovascular health by helping to maintain normal blood platelet aggregation, which contributes to healthy blood flow. Provexis licenses its technology to business partners for inclusion in their consumer products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2018-02-05 15:16
Holding(s) in Company
English HTML 63.8 KB
2018-01-31 09:21
Directorate Change - Krijn Rietveld
English HTML 10.3 KB
2018-01-02 08:00
Grant of Share Options
English HTML 37.9 KB
2017-12-29 08:09
Half-year Report
English HTML 143.0 KB
2017-12-04 08:00
Patent application - Fruitflow and air pollution
English HTML 23.3 KB
2017-11-10 17:40
Second Price Monitoring Extn
English HTML 7.5 KB
2017-11-10 17:35
Price Monitoring Extension
English HTML 7.5 KB
2017-11-02 17:41
Second Price Monitoring Extn
English HTML 7.5 KB
2017-11-02 17:35
Price Monitoring Extension
English HTML 7.5 KB
2017-10-31 17:40
Second Price Monitoring Extn
English HTML 7.5 KB
2017-10-31 17:35
Price Monitoring Extension
English HTML 7.5 KB
2017-10-03 18:10
Result of AGM
English HTML 15.2 KB
2017-09-26 16:44
Study Publication
English HTML 22.8 KB
2017-09-07 09:00
Preliminary Results
English HTML 322.5 KB
2017-08-04 10:00
Holding(s) in Company
English HTML 49.1 KB

Automate Your Workflow. Get a real-time feed of all PROVEXIS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PROVEXIS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PROVEXIS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.